Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.15513
Abstract: Reports suggested the potential occurrence of peripheral neuropathies (PN) in patients treated with BRAF (BRAFi) and/or MEK inhibitors (MEKi) for BRAFâactivated tumours. We aimed to better characterize these PN. We queried the French pharmacovigilance database… read more here.
Keywords: braf mek; brafi meki; treatment; neuropathies braf ... See more keywords